April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Photoreceptor-Targeted Gene Delivery Using Intravitreally Administered AAV Vectors in Dogs
Author Affiliations & Notes
  • Ryan F Boyd
    Small Animal Clinical Sciences, Michigan State University, East Lansing, MI
  • Sanford L Boye
    Ophthalmology, University of Florida, Gainesville, FL
  • Shannon Boye
    Ophthalmology, University of Florida, Gainesville, FL
  • William W Hauswirth
    Ophthalmology, University of Florida, Gainesville, FL
  • Andras M Komaromy
    Small Animal Clinical Sciences, Michigan State University, East Lansing, MI
  • Simon M Petersen-Jones
    Small Animal Clinical Sciences, Michigan State University, East Lansing, MI
  • Joshua T Bartoe
    Small Animal Clinical Sciences, Michigan State University, East Lansing, MI
  • Footnotes
    Commercial Relationships Ryan Boyd, None; Sanford Boye, None; Shannon Boye, None; William Hauswirth, AGTC (P); Andras Komaromy, None; Simon Petersen-Jones, None; Joshua Bartoe, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3331. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ryan F Boyd, Sanford L Boye, Shannon Boye, William W Hauswirth, Andras M Komaromy, Simon M Petersen-Jones, Joshua T Bartoe; Photoreceptor-Targeted Gene Delivery Using Intravitreally Administered AAV Vectors in Dogs. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3331.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Effective delivery of therapeutic transgenes to retinal photoreceptors using adeno-associated virus (AAV) vectors has traditionally required subretinal injection. Photoreceptor transduction ability following intravitreal AAV injection has improved in rodent models through the use of vectors containing capsid amino acid substitutions; but remains limited in large animal models. Our study compared the transduction efficiency of two novel GFP-expressing AAV vectors containing multiple capsid amino acid substitutions following intravitreal injection in dogs. The ability of two photoreceptor-specific promoters to drive targeted transgene expression was also evaluated.

Methods: Six normal dogs were used. All AAV vectors were intravitreally injected at the inner surface of the retina at a dose of 4 x 1011 vector genomes. Two AAV serotype 2/2 vectors were used, one with four capsid Tyr-to-Phe substitutions, and the other with four Tyr-to-Phe and one Thr-to-Val substitution. Each vector genome contained a GFP reporter gene driven by either the interphotoreceptor binding protein (IRBP) promoter or the transducin subunit alpha-2 (GNAT2) promoter with an IRBP enhancer; resulting in four different vector constructs. Each vector construct was injected into three eyes (4 vectors X 3 eyes = 6 dogs). In vivo fundoscopic imaging was performed for a period of eight weeks to monitor GFP expression. Immunohistochemistry was performed on retinal cryosections to evaluate the transduction efficiency and tropism of the vectors.

Results: The two AAV vectors packaged with the IRBP promoter drove expression in rod and cone photoreceptors exclusively, without significant differences in the number of cells transduced. Overall retinal transduction efficiency for both AAV vectors containing the IRBP promoter was approximately 4% of cones and 2% of rods. A significantly higher level of photoreceptor transduction occurred in regions underlying retinal vasculature, with local transduction efficiencies of up to 31% of cones and 14% of rods. Vectors carrying the GNAT2 promoter produced cone-specific GFP expression, although this occurred at a low level that was not quantifiable.

Conclusions: AAV vectors packaged with the IRBP promoter limit intraocular transgene expression to retinal photoreceptors alone following intravitreal delivery in dogs. Overall retinal transduction is limited; but local regions exhibit increased efficiency.

Keywords: 538 gene transfer/gene therapy • 648 photoreceptors • 763 vitreous  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×